If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
2
Followers on Owler
Immatics is a developer of advanced immunotherapies for cancer treatment...
Read more
Overview
Funding
News & Insights
Immatics is a developer of advanced immunotherapies for cancer treatment...
Read more
CEO
Paul Higham
CEO Approval Rating
68/100
Weigh In
01/2000
Tuebingen
Baden-Württemberg
Private
Pharmaceuticals & Biotechnology
Add Sector
2834
NAICS listing
http://www.immatics.net
Est. Annual Revenue
$5.0-25M
Agree?
Yes
No
Est. Employees
250-500
Agree?
Yes
No
Funding
$46.2M
News
Latest News
May 14, 2018
FierceBiotechIT
immatics: Stephen Eck leaves Aravive CEO job to join Immatics
Follow and Get Alerts
Trending Companies
